Published in Antimicrob Agents Chemother on January 01, 1981
Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess. N Engl J Med (2016) 3.28
Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutr Metab (Lond) (2009) 0.96
Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique. Antimicrob Agents Chemother (1981) 0.90
Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques. Br J Clin Pharmacol (2003) 0.88
A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection. Clin Infect Dis (2016) 0.75
Septicemia due to susceptible Enterococcus faecalis despite prophylaxis with trimethoprim-sulfamethoxazole. Eur J Clin Microbiol Infect Dis (1997) 0.75
A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid. Scand J Clin Lab Invest (1953) 8.04
Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid. Antimicrob Agents Chemother (1977) 1.55
Penetration of four cephalosporins into tissue fluid in man. Lancet (1978) 1.38
Transfer of penicillin G and ampicillin into human skin blisters induced by suction. Scand J Infect Dis Suppl (1978) 1.36
Human leucocyte migration: studies with an improved skin chamber technique. Acta Pathol Microbiol Scand C (1977) 1.25
Increased plasma binding of quinidine after surgery: a preliminary report. Eur J Clin Pharmacol (1976) 1.23
Distribution of trimethoprim/sulphadiazine in plasma, tissue and synovial fluids. Vet Rec (1978) 1.08
The tissue cage model in the distribution of antibacterial agents. Scand J Infect Dis Suppl (1978) 0.88
Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography. J Chromatogr (1978) 0.86
Bacampicillin, Ampicillin, Cephalothin, and Cephapirin levels in human blood and interstitial fluid. Antimicrob Agents Chemother (1979) 0.83
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med (1993) 4.88
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis (1989) 3.66
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin Pharmacol Ther (1971) 2.45
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) (1986) 1.83
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
Disease and acetylation polymorphism. Clin Pharmacokinet (1977) 1.56
Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis (1989) 1.44
[Triazolam for the last time?]. Tidsskr Nor Laegeforen (1991) 1.39
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis (2003) 1.39
Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest (1992) 1.35
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med (1996) 1.33
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe. Eur J Clin Pharmacol (1990) 1.30
Systemic meningococcal disease: a model infection to study acute endotoxinemia in man. Prog Clin Biol Res (1988) 1.30
The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1975) 1.30
Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges. Antimicrob Agents Chemother (1986) 1.27
Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res (2001) 1.23
Increased plasma binding of quinidine after surgery: a preliminary report. Eur J Clin Pharmacol (1976) 1.23
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis (2004) 1.21
Vasoconstriction in isolated blood-perfused rabbit lungs and its inhibition by cresols. Acta Physiol Scand (1966) 1.20
Disinfection of the hands of ward personnel. A comparison of six disinfectants. Acta Med Scand (1968) 1.17
Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet (1986) 1.17
Extravascular penetration of highly protein-bound flucloxacillin. Antimicrob Agents Chemother (1986) 1.17
Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis (1992) 1.16
Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice. J Reticuloendothel Soc (1974) 1.14
Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics". Scand J Infect Dis Suppl (1997) 1.12
Transvascular fluid balance in the lung. J Physiol (1969) 1.08
Hand carriage of gram-negative bacilli and Staphylococcus aureus. Br Med J (1973) 1.08
Fever in general practice. I. Frequency and diagnoses. Fam Pract (1992) 1.07
Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. Am Heart J (1986) 1.06
Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res (1985) 1.05
Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res (1990) 1.05
Severity of meningococcal disease: assessment by factors and scores and implications for patient management. Rev Infect Dis (1991) 1.02
Electrical stimulation of adult rat cardiomyocytes in culture improves contractile properties and is associated with altered calcium handling. Basic Res Cardiol (1997) 1.02
The early phase of meningococcal disease. NIPH Ann (1983) 1.02
Plasma concentration of diazepam and N-desmethyldiazepam in children after a single rectal or intramuscular dose of diazepam. Eur J Clin Pharmacol (1978) 1.00
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. J Pediatr (1971) 0.99
Fish oil and plasma fibrinogen. BMJ (1988) 0.98
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res (1989) 0.98
The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis (1996) 0.98
The effect of bradykinin, kallidin and eledoisin upon the pulmonary vascular bed of an isolated blood-perfused rabbit lung preparation. Acta Physiol Scand (1966) 0.98
Upregulation of the cardiac monocarboxylate transporter MCT1 in a rat model of congestive heart failure. Circulation (2001) 0.98
The inhibitory effect of various phenols upon ATP-induced vasoconstriction in isolated perfused rabbit lungs. Acta Physiol Scand (1968) 0.97
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin. Eur J Clin Pharmacol (1992) 0.97
Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept (1989) 0.97
Studies on methanol poisoning. Acta Med Scand (1982) 0.96
Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lab Invest (1993) 0.95
LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine (1994) 0.94
A Norwegian nosocomial outbreak of methicillin-resistant Staphylococcus aureus resistant to fusidic acid and susceptible to other antistaphylococcal agents. J Hosp Infect (1999) 0.94
Pharmacokinetic studies of antibacterial agents using the suction blister method. Scand J Infect Dis Suppl (1990) 0.94
Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res (2000) 0.94
Macrophage tropism: fact or fiction? J Leukoc Biol (1997) 0.93
Effects of prostaglandin E1 and adrenaline on the pulmonary vascular resistance (PVR) in isolated rabbit lungs. Life Sci (1967) 0.92
Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev (2012) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Different binding of 125I-LPS to plasma proteins from persons with high or low HDL. Scand J Clin Lab Invest (1996) 0.92
Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. Eur J Clin Pharmacol (1981) 0.91
Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol (1990) 0.91
Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine. Clin Pharmacol Ther (1982) 0.91
DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet (1989) 0.91
Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Thromb Haemost (1996) 0.91
Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog (1992) 0.91
Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG). Eur J Clin Pharmacol (1986) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
A study of hospital urinary tract infections. J Urol (1973) 0.90
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int (1992) 0.90
Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG). Eur J Clin Pharmacol (1986) 0.90
LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine (1996) 0.89
Plasma concentrations of diazepam and N-desmethyldiazepam in newborn infants after intravenous, intramuscular, rectal and oral administration. Acta Paediatr Scand (1978) 0.89
Purification of the gramicidin S synthesizing activity in Bacillus brevis extracts. Eur J Biochem (1968) 0.89
Post-operative wound infection. Predisposing factors and the effect of a reduction in the dissemination of staphylococci. Acta Med Scand Suppl (1970) 0.89
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg (1996) 0.89
Isometric force and endurance in soleus muscle of thyroid hormone receptor-alpha(1)- or -beta-deficient mice. Am J Physiol Regul Integr Comp Physiol (2000) 0.89
Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest (2000) 0.88
Maintenance therapy with a new retard tablet preparation of procainamide. Am Heart J (1976) 0.88
Gas-chromatographic determination of disopyramide and its mono-N-dealkylated metabolite in serum with use of a nitrogen-selective detector. Clin Chem (1980) 0.88
Reduced myocardial Na+, K(+)-pump capacity in congestive heart failure following myocardial infarction in rats. J Mol Cell Cardiol (1998) 0.88
Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients. HIV Med (2006) 0.88
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost (1996) 0.88
Drug binding in sera deficient in lipoproteins, albumin or orosomucoid. Br J Clin Pharmacol (1983) 0.88
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma. Scand J Clin Lab Invest (1971) 0.87
Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations. Acta Neurol Scand (1985) 0.87
Aging, cigarette smoking and oral theophylline requirement. Eur J Clin Pharmacol (1981) 0.87
Plasma binding of disopyramide and mono-N-dealkyldisopyramide. Br J Clin Pharmacol (1982) 0.87
Thrombin generation during collection and storage of blood. Vox Sang (1986) 0.87